Sudan Loganathan

Stock Analyst at Stephens & Co.

(0)
# 4691
Out of 5,218 analysts
23
Total ratings
26.32%
Success rate
-19.09%
Average return
17 Stocks
Name Action Price Target Current % Upside Ratings Updated
Elevation Oncology
Reiterates: Overweight
5 5
0.64 681.25% 2 Dec 6, 2024
Actinium Pharma
Reiterates: Overweight
5 5
1.21 313.22% 2 Nov 19, 2024
Catalyst Pharmaceuti...
Initiates Coverage On: Overweight
35
21.36 63.86% 1 Nov 18, 2024
IDEAYA Biosciences
Initiates Coverage On: Overweight
51
25.19 102.46% 1 Nov 18, 2024
C4 Therapeutics
Initiates Coverage On: Equal-Weight
4
4.38 -8.68% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
65
41.98 54.84% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
55
19.42 183.21% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
25
13.8 81.16% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
1.87 220.86% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
30
12.59 138.28% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
13
1.63 697.55% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 29
35.01 -17.17% 2 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
31 31
20.21 53.39% 2 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
25 25
12.09 106.78% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
0.43 1062.79% 2 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
140
93.28 50.09% 1 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
2.29 773.36% 1 May 14, 2024